MOLECULAR

COMMERCIALIZATION

CHEMISTRY

MISSION STATEMENT

As responsible members of the global health care community, our mission is to secure comprehensive knowledge and coverage of life sciences and healthcare with cost-effective prices in the market, proven clinical and analytical accuracy and availability of large numbers of tests. KPC Biotech is a unique powerful entity product of the sum of its parts. Which include the development and manufacture of safe and reliable Karma Care Line of tests, the distribution and world wide network commercialization of IVD and Life Sciences which improve quality of life for patients and consumers and the creation of value for our shareholders and partners.

today oyster perpetual pearlmaster 29 replica may be the earliest brand still running a business.see post from china.

Molecular

KPC Biotech Molecular Diagnostic Laboratory

Commercialization

Access to Products Product Distribution Global Commercialization Network & Capabilities

Chemistry

Clinical Research Organization (CRO) Pharmaceutical Services

KPC BIOTECH IS A UNIQUE POWERFUL ENTITY PRODUCT OF THE SUM OF ITS PARTS

ROADMAP TO COMMERCIALIZATION

Pre-clinical and Clinical Validation
Pre-commercialization with CRO
Molecular Diagnostics Clinical Laboratory
Early Commercialization with Molecular Lab
Commercialization Selling the Box
Full Commercialization with Distribution

WE'RE FOCUSING ON PROVIDING HIGH-QUALITY, COST-SENSITIVE COVID-19 SOLUTIONS THROUGH OUR KARMACARE COVID-19 PRODUCT LINE

  • Only source of SARS-CoV-2 tests with its own clinical, scientific, and hospital and laboratory infrastructure.
  • Real in-house selection, validation of products, and quality control.
  • Real-in house expertise to provide clinical insights for interpretation, implementation of epidemiological surveillance programs.
  • KPC Biotech operates on a global network across the US, Mexico, India, and Latin America.

STRATEGIC PARTNERSHIP & COLLABORATIONS

With the strategic partnership of KPC Health that includes hospitals, UCI and specialized clinics we are the only source of SARS-CoV-2 tests with its own clinical, scientific, and hospital and laboratory infrastructure.

Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products.

Based on the greatest needs and the potential to do the most good, we work with partners across the world, including the Bill and Melinda Gates Foundation, the World Health Organization, Doctors Without Borders, UNICEF, and many others.

ABOUT KPC HEALTH

Biotech is part of the KPC Group of companies.The KPC Group is a global leader in healthcare, pharmaceuticals, education, engineering and real estate. Founded by world renowned orthopedic surgeon and entrepreneur Dr. Kali Chaudhuri, Founder and Chairman, The KPC Group, has amassed over $10 billion in assets, including hospitals, clinics, schools, commercial real estate properties, and agricultural research centers. As pioneers in technology for the healthcare industry, the KPC Group healthcare division and KPC Health has successfully established an integrated healthcare system consisting of acute care hospitals, Independent Physicians Associations (IPAs), medical groups, urgent care facilities, and various multi-specialty medical facilities throughout the western United States.